Ahmet Hoke, MD
Enriched profileProfessor of Neurology and Neuroscience; W. W. Smith Charitable Trust Professor of Neuroimmunology; Director, Daniel B. Drachman Division of Neuromuscular Diseases; Director, Merkin Peripheral Neuropathy and Nerve Regeneration Center · Johns Hopkins University School of Medicine
Ahmet Hoke is Professor of Neurology and Neuroscience; W. W. Smith Charitable Trust Professor of Neuroimmunology; Director, Daniel B. Drachman Division of Neuromuscular Diseases; Director, Merkin Peripheral Neuropathy and Nerve Regeneration Center at Johns Hopkins University School of Medicine. OpenAlex indexes 349 publications with 16,636 citations (h-index 68); ClinicalTrials.gov lists 2 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Neurology profiles in the findmyKOL directory.
Data verified 18 Oct 2026
Overview
Updated 22 Oct 2026
Ahmet Hoke, M.D., is Professor of Neurology and Neuroscience at Johns Hopkins University School of Medicine. The public record shows 349 publications with 16,636 citations (h-index 68), centered on Nerve injury and regeneration, Peripheral Neuropathies and Disorders, Hereditary Neurological Disorders. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 6 companies, 12 NIH-funded awards (2002–2026).
- Most recent indexed publication: 2026 · Aging cell
- Top research focus: Nerve injury and regeneration
- 2 registered trials on ClinicalTrials.gov
- Open Payments reporting from 6 companies
Generated from the cited public record · current as of 22 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 36 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 163.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 22 Oct 2026
Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:
- Evaluation of Nicotinamide Riboside in Prevention of Small Fiber Axon Degeneration and Promotion of Nerve Regeneration
Sponsor: Johns Hopkins University
- Tesamorelin to Improve Functional Outcomes After Peripheral Nerve Injury
Sponsor: Johns Hopkins University
Industry payments
Updated 22 Oct 2026
6 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year20253 payments$18,661openpaymentsdata.cms.gov ↗
- VERTEX PHARMACEUTICALS INCORPORATEDProgram year20259 payments
- AstraZeneca UK LimitedProgram year20253 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
60%SNRI60%Duloxetine Hcl100%Part D<11 patientsCardiovascular
40%Central alpha-2 Adrenergic Agonist40%Guanfacine Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 22 Oct 2026
12 NIH research awards on record, funded 2002–2026 per NIH RePORTER. The latest:
- Macrophage-targeted dendrimer 2-PMPA for the treatment of age-related sarcopenia
Johns Hopkins University
FY2026$551,536R01AG078181 - JHU Center for the Advancement of HIV Neurotherapeutics (JHU CAHN) - Development Core
Johns Hopkins University
FY2026$248,248P30MH075673 - Macrophage-targeted dendrimer 2-PMPA for the treatment of age-related sarcopenia
Johns Hopkins University
FY2025$540,506R01AG078181
Publications
Updated 22 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Bi- and Mono-Allelic RFC1 Expansion in a North American Cohort With Idiopathic Axonal Neuropathy.
Annals of clinical and translational neurology
Article2026 - Homozygous RFC1 AAGGG Repeat Expansions Are Common in Idiopathic Peripheral Neuropathy.
Annals of neurology
Article2026 - A 73-Year-Old Man With Several Years of Difficulty Climbing Stairs and Frequent Tripping.
Annals of clinical and translational neurology
Case Report2026
Most-cited works
by citation count (OpenAlex)- 01Advances in peripheral nerve regenerationReview759 citations2013
- 02Differences between human and mouse embryonic stem cellsArticle719 citations2004
- 03A framework for diagnosing and classifying intensive care unit-acquired weaknessArticle700 citations2009
- 04The effect of the alignment of electrospun fibrous scaffolds on Schwann cell maturationArticle521 citations2007
- 05
Network
Updated 22 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 22 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
Editorial & leadership roles
journal and society appointments- Editor-in-Chief
Annals of Clinical and Translational Neurology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →myana.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →2025.myana.org ↗
- Ex-Officio Member
Board of Directors of the American Neurological Association
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medifind.com ↗ - Vice-President
Toxic Neuropathy Consortium
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medifind.com ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →inbt.jhu.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →inbt.jhu.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →inbt.jhu.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →inbt.jhu.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →inbt.jhu.edu ↗
Secondary affiliations
appointments beyond the home institution- Johns Hopkins Hospital; ALS Clinic
Charcot-Marie Tooth Center, Peripheral Nerve Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Julie Brahmer, MD
Johns Hopkins University School of Medicine
Kenneth Pienta, MD
Johns Hopkins University School of Medicine
Michelle Petri, MD
Johns Hopkins University School of Medicine
Harry Quigley, MD
Johns Hopkins University School of Medicine
Bruce Miller, MD
University of California, San Francisco (UCSF)
Brett Kissela, MD
Medical College of Wisconsin
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine